Certara Products Archives | Certara

Press Release

Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance

FY 2025 Revenue of $418.8M (9% growth) and Adj. EBITDA of $134.5M (10% growth) Fourth…

CertaraFebruary 26, 2026

Webinar

Ready for ESG NextGen, or still submitting like it’s 2015?

CertaraFebruary 5, 2026

Conference

AI in Drug Discovery 2026

CertaraJanuary 30, 2026

Press Coverage

The data fragmentation problem holding drug discovery back

Explore how fragmented data across the drug discovery DMTA cycle impedes progress, and discover how…

CertaraJanuary 21, 2026

Webinar

CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access

CertaraJanuary 14, 2026

On-Demand Webinar

Safety First: Uncovering the Clinical Risks Inside Your Compound Screening Data

Learn how to interpret screening assay data to predict clinical off-target risk with ToxStudio® and…

CertaraJanuary 13, 2026

Fact Sheet

Add Off-target Risk Profiling to Your Analyses

Certara's cheminformatics solution, D360, supports a key feature of Secondary Intelligence: a low-medium-high ranking of…

CertaraJanuary 5, 2026

On-Demand Webinar

From Unstructured Data to Dose Insights: Applying Modern AI to Exposure Bracketing

CertaraDecember 16, 2025

On-Demand Webinar

Implementing AI in Medical Writing: Prepare Today for Tomorrow’s Efficiency [Japanese Webinar]

CertaraDecember 10, 2025

On-Demand Webinar

Why Upgrade to Marvin? Unlocking Speed, Accuracy, and Scientific Intelligence

Watch this webinar to see how Marvin outperforms Marvin JS with faster chemical drawing, advanced…

CertaraDecember 8, 2025

© 2026 Certara. All Rights Reserved. | Legal | Privacy policy